Sales pricing models based on returns: Bundling vs. add-on

被引:4
|
作者
Nie, Tengfei [1 ]
Song, Bo [1 ]
Zhang, Jianghua [1 ]
机构
[1] Shandong Univ, Sch Management, Jinan 250100, Peoples R China
基金
中国国家自然科学基金;
关键词
Consumer return; Product pricing; Freight insurance; Bundling sales; Add-on sales; PRODUCTS; RETAILERS; BEHAVIOR; POLICIES; REVIEWS; CHANNEL; QUALITY; SERVICE; IMPACT;
D O I
10.1016/j.omega.2024.103038
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
With the proliferation of e -commerce, there has been a remarkable surge in the volume of products sold online, accompanied by a corresponding increase in product returns. In order to stimulate consumer demand, retailers have adopted various promotional strategies, among which the bundling and add-on sales have emerged as the most prevalent. Nevertheless, there is currently no clearly dominant promotion model considering consumer return behavior. Consequently, we construct a game -theory model that considers product returns in the settings of an online retailer, an insurance company, and a continuum of consumers. Within our model, consumers are confronted with uncertainty regarding their valuations and only ascertain the true value of a purchased product after acquisition. Moreover, retailers must carefully consider the tradeoff between the bundling and add-on models: bundling sales may sell more products, but return products increase; on the other hand, add-on sales offer the advantage of single item returns but may result in a decrease in overall product sales. Our findings yield several noteworthy conclusions warranting further examination. First, add-on product substandard rate (Proportion of add-on products with substandard quality to all add-on products) has a significant influence on the retailer's choice of sales model. More specifically, when the add-on product substandard rate is lower, retailers will definitely choose bundling sales. Otherwise, the retailer's choice of sales model depends on both core product price and degree of discount. Second, in bundling sales, the better the match between core product and add-on product, the higher the retailer's profit. However, in add-on sales, highly matched add-on product may hurt the retailer's profit. Finally, add-on sales is a better choice for commercial groups that have both sales companies and insurance companies.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] EFFECTIVENESS OF QUETIAPINE XR VS. SERTRALINE IN ACUTE BIPOLAR DEPRESSION AS ADD-ON THERAPY TO PREVIOUS MOOD STABILIZER TREATMENT: A PILOT STUDY
    Prieto, E.
    Vazquez-Noguerol, R.
    Franco, M.
    Artal, J.
    Montejo, A. L.
    Gonzalez-Pinto, A.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [32] Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial
    Correll, Christoph U.
    Sikich, Linmarie
    Reeves, Gloria
    Johnson, Jacqueline
    Keeton, Courtney
    Spanos, Marina
    Kapoor, Sandeep
    Bussell, Kristin
    Miller, Leslie
    Chandrasekhar, Tara
    Sheridan, Eva M.
    Pirmohamed, Sara
    Reinblatt, Shauna P.
    Alderman, Cheryl
    Scheer, Abigail
    Borner, Irmgard
    Bethea, Terrence C.
    Edwards, Sarah
    Hamer, Robert M.
    Riddle, Mark A.
    WORLD PSYCHIATRY, 2020, 19 (01) : 69 - 80
  • [33] Bill-and-keep vs. cost-based access pricing revisited
    Berger, U
    ECONOMICS LETTERS, 2005, 86 (01) : 107 - 112
  • [34] Dynamic pricing and inventory control: robust vs. stochastic uncertainty models-a computational study
    Adida, Elodie
    Perakis, Georgia
    ANNALS OF OPERATIONS RESEARCH, 2010, 181 (01) : 125 - 157
  • [35] Asset pricing models in emerging markets: Factorial approaches vs. information stochastic discount factor'
    Gonzalez-Sanchez, Mariano
    FINANCE RESEARCH LETTERS, 2022, 46
  • [36] Resource Utilization (RU) and Costs Associated with Use of Add-On Therapy with Rosiglitazone (RSG) vs. Sulfonylurea (SU) to Metformin (MET) Monotherapy (Mono)
    Ma, Li
    Lee, Won Chan
    Menditto, Laura
    Arondekar, Bhakti
    DIABETES, 2009, 58 : A154 - A154
  • [37] Treat 4 Ramadan: A Randomised Control Trial Comparing Liraglutide vs. a Sulphonylurea as Add-On to Metformin in Patients With Established Type 2 Diabetes
    Davies, Melanie J.
    Brady, Emer M.
    Gray, Laura J.
    Saeed, Mujahid
    Wasim, Hanif
    Khunti, Kamlesh
    DIABETES, 2013, 62 : A661 - A661
  • [38] Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
    Lyu, Young Sang
    Hong, Sangmo
    Lee, Si Eun
    Cho, Bo Young
    Park, Cheol-Young
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [39] Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
    Young Sang Lyu
    Sangmo Hong
    Si Eun Lee
    Bo Young Cho
    Cheol-Young Park
    Cardiovascular Diabetology, 23
  • [40] Comparison of Research Based vs. Industry Developed PSS Models
    Ryan, Linda
    Tormey, David
    Share, Perry
    EXPLORING SERVICES SCIENCE, 2011, 82 : 216 - +